UBS Group AG - RAIN THERAPEUTICS INC ownership

RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 39 filers reported holding RAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of RAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,454
-37.3%
8,647
-12.8%
0.00%
Q2 2023$11,893
-26.0%
9,911
+438.6%
0.00%
Q1 2023$16,082
+120.2%
1,840
+101.5%
0.00%
Q4 2022$7,304
-8.7%
913
-46.2%
0.00%
Q3 2022$8,000
+100.0%
1,698
+145.4%
0.00%
Q1 2022$4,000
-94.7%
692
-88.3%
0.00%
Q4 2021$76,0005,9150.00%
Other shareholders
RAIN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 2,034,552$1,753,3770.54%
TANG CAPITAL MANAGEMENT LLC 3,740,341$3,223,4260.46%
PVG ASSET MANAGEMENT CORP 47,520$40,9520.28%
Acuitas Investments, LLC 409,256$352,6970.21%
Ghost Tree Capital, LLC 325,000$280,0850.09%
BVF INC/IL 3,526,729$3,039,3350.08%
BML Capital Management, LLC 72,926$62,8480.06%
Boxer Capital, LLC 1,152,212$992,9760.05%
Marquette Asset Management, LLC 84,135$72,5080.02%
Shay Capital LLC 31,730$27,3450.00%
View complete list of RAIN THERAPEUTICS INC shareholders